UNSPSC 51441901: Acetrizoic acid

This classification denotes a contrast agent with the molecular formula C9H6I3NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 24256BQV7M, chemically known as 3-(acetylamino)-2,4,6-triiodobenzoic acid but more generally known as acetrizoic acid, which bears U.S. National Institutes of Health Compound Identifier 6806. The European Medicines Agency schedules Acetrizoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00256MIG.

The World Health Organization schedules acetrizoic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule Acetrizoic acid under HS 29242995. SMILES: IC1C(NC(=O)C)C(I)CC(I)C1C(=O)O.

UNSPSC 51441901 Acetrizoic acid is a Commodity code showing minimal recent state and local procurement activity directly aligned with its nominal scope. The two most recent opportunities tagged to this code diverge significantly from acetrizoic acid procurement: Broward County Aviation Department issued an RFI on June 25, 2026, closing July 28, 2026, for maintenance services on Rapiscan X-ray inspection systems (a sole-source equipment-support contract), and Pasco County, Florida issued an RFQ on June 3, 2026, closing June 26, 2026, for copper sulfate crystals and liquid copper sulfate on an as-needed basis. Neither solicitation concerns acetrizoic acid or related contrast agents. The code does not reflect purchasing patterns in active state and local procurement cycles at this time.

The geographic activity evident in the source is limited to Florida, with no supporting data on issuing-body mix, repeat buyers, or procurement concentration. Without recent opportunities demonstrating actual acetrizoic acid demand from state and local jurisdictions, assessing market traction under this code is not feasible from the available source material.